Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice

Infection and Immunity

Volumn 66, Issue 3, 1998, Pages 912-922

  Bergeron, Yves ^b   Ouellet, Nathalie ^b   Deslauriers, Anne Marie ^b   Simard, Marie ^b   Olivier, Martin ^b   Bergeron, Michel G ^a  

^a LAVAL UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; LEUKOTRIENE B4; LUNG SURFACTANT; NITRIC OXIDE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; FATALITY; FEMALE; HOST RESISTANCE; LUNG ALVEOLUS CELL TYPE 2; LUNG EDEMA; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; TACHYPNEA;

EID: 0031912785     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.3.912-922.1998     Document Type: Article

References (95)

1. Abbas, A. K., A. H. Lichtman, and J. S. Pober. 1991. Effector mechanisms of immune responses. Cytokines, p. 232-235. In M. J. Wonsiewicz (ed.), Cellular and molecular immunology. W. B. Saunders Company, Philadelphia, Pa.
2. Aihara, M., T. Nakazawa, K. Dobashi, T. Joshita, M. Kojima, M. Onai, and M. Mori. 1997. A selective pulmonary thrombosis associated with sepsis-induced disseminated intravascular coagulation. Intern. Med. 36:97-101.
3. Akaike, T., Y. Noguchi, S. Ijiri, K. Setoguchi, M. Suga, Y. M. Zheng, B. Dietzschold, and H. Maeda. 1996. Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc. Natl. Acad. Sci. USA 93:2448-2453.
4. Amura, C. R., P. A. Fontan, N. Sanjuan, and D. O. Sordelli. 1994. The effect of treatment with interleukin-1 and tumor necrosis factor on Pseudomonas aeruginosa lung infection in a granulocytopenic mouse model. Clin. Immunol. Immunopathol. 73:261-266.
5. Anderson, V. M., and T. Turner. 1991. Histopathology of childhood pneumonia in developing countries. Rev. Infect. Dis. 13(Suppl. 6):S470-S476.
6. Antonini, J. M., K. Van Dyke, M. DiMatteo, and M. J. Reason 1995. Attenuation of acute inflammatory effects of silica in rat lung by 21-aminosteroid, U74389G. Inflammation 19:9-21.
7. Azoulay-Dupuis, E., J. P. Bedos, E. Vallée, and J. J. Pocidalo. 1991. Comparative activity of fluorinated quinolones in acute and subacute Streptococcus pneumoniae pneumonia models: efficacy of temafloxacin. J. Antimicrob. Chemother. 28(Suppl. C):45-53.
8. Azoulay-Dupuis, E., E. Vallée, J. P. Bedos, M. Muffat-Joly, and J. J. Pocidalo. 1991. Prophylactic and therapeutic activities of azithromycin in a mouse model of pneumococcal pneumonia. Antimicrob. Agents Chemother. 35:1024-1028.
9. Beauchamp, D., P. Gourde, M. Simard, and M. G. Bergeron. 1994. Subcellular distribution of daptomycin given alone or with tobramycin in renal proximal tubular cells. Antimicrob. Agents Chemother. 38:189-194.
10. Bergeron, Y., N. Ouellet, M. Simard, M. Olivier, and M. G. Bergeron. 1997. Immunotherapy of pneumococcal pneumonia with cefodizime, abstr. 15. In Abstracts of the 4th International Congress on Biological Response Modifiers. The Inter-American Society for Chemotherapy, Imedex USA, Alpharetta, Ga.
11. Bergeron, Y., A. M. Deslauriers, M. Olivier, M. Simard, D. Beauchamp, and M. G. Bergeron. 1995. Novel strategies to control the inflammatory response during lethal bacterial pneumonia. Can. J. Infect. Dis. 6(Suppl. C):418C. (Abstract.)
12. Boulnois, G. J. 1992. Pneumococcal proteins and the pathogenesis of disease caused by Streptococcus pneumoniae. J. Gen. Microbiol. 138:249-259.
13. Broug-Holub, E., G. B. Toews, J. F. Van Iwaarden, R. M. Strieter, S. L. Kunkel, R. Paine, and T. J. Standiford. 1997. Alveolar macrophages are required for protective pulmonary defenses in murine Klebsiella pneumonia: elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival. Infect. Immun. 65:1139-1146.
14. Buret, A., M. L. Dunkley, G. Pang, R. L. Clancy, and A. W. Cripps. 1994. Pulmonary immunity to Pseudomonas aeruginosa in intestinally immunized rats: roles of alveolar macrophages, tumor necrosis factor alpha, and interleukin-1 alpha. Infect. Immun. 62:5335-5343.
15. Cassatella, M. A. 1995. The production of cytokines by polymorphonuclear neutrophils. Immunol. Today 16:21-26.
16. Chollet-Martin, S., P. Montravers, C. Gibert, C. Elbim, J. M. Desmonts, J. Y. Fagon, and M. Gougerot-Pocidalo. 1993. High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome. Infect. Immun. 61:4553-4559.
17. Coonrod, J. D., R. Varble, and M. C. Jarrells. 1990. Species variation in the mechanism of killing of inhaled pneumococci. J. Lab. Clin. Med. 116:354-362.
18. Cundell, D., H. R. Masure, and E. I. Tuomanen. 1995. The molecular basis of pneumococcal infection: a hypothesis. Clin. Infect. Dis. 21(Suppl. 3): S204-S212.
19. Cundell, D. R., and E. I. Tuomanen. 1994. Receptor specificity of adherence of Streptococcus pneumoniae to human type-II pneumocytes and vascular endothelial cells in vitro. Microb. Pathog. 17:361-374.
20. Czuprynski, C. J., M. Haak-Frendscho, N. Maroushek, and J. F. Brown. 1992. Effects of recombinant human interleukin-6 alone and in combination with recombinant interleukin-1 alpha and tumor necrosis factor alpha on antibacterial resistance in mice. Antimicrob. Agents Chemother. 36:68-70.
21. Davis, C. C., M. A. Mellencamp, and L. C. Preheim. 1991. A model of pneumococcal pneumonia in chronically intoxicated rats. J. Infect. Dis. 163: 799-805.
22. Dehoux, M. S., A. Boutten, J. Ostinelli, N. Seta, M. C. Dombret, B. Crestani, M. Deschenes, J. L. Trouillet, and M. Aubier. 1994. Compartmentalized cytokine production within the human lung in unilateral pneumonia. Am. J. Respir. Crit. Care Med 150:710-716.
23. 20a.Deslauries, A. M., Y. Bergeron, M. Olivier, D. Beauchamp, P. Gourde, and M. G. Bergeron. 1995. The role of host defense mechanisms in a murine model of Streptococcus pneumoniae pneumonia. Can. J. Infect. Dis. 6(Suppl. C):419C. (Abstract.)
24. Doerschuk, C. M., R. K. Winn, H. O. Coxson, and J. M. Harlan. 1990. CD18-dependent and -independent mechanisms of neutrophil emigration in the pulmonary and systemic microcirculation of rabbits. J. Immunol. 144: 2327-2333.
25. Dunne, D. W., D. Resnick, J. Greenberg, M. Krieger, and K. A. Joiner. 1994. The type I macrophage scavenger receptor binds to gram-positive bacteria and recognizes lipoteichoic acid. Proc. Natl. Acad. Sci. USA 91:1863-1867.
26. Elferink, J. G. R., and B. E. VanUffelen. 1996. The role of cyclic nucleotides in neutrophil migration. Gen. Pharmacol. 27:387-393.
27. Fahey, T. J., K. J. Tracey, and A. Cerami. 1992. Tumor necrosis factor (cachectin) and the adult respiratory distress syndrome, p. 175-183. In A. P. Fishman (ed.), Update: pulmonary diseases and disorders, McGraw-Hill, Montreal, Québec, Canada.
28. Fox-Dewhurst, R., M. K. Alberts, O. Kajikawa, E. Caldwell, M. C. Johnson, et al. 1997. Pulmonary and systemic inflammatory responses in rabbits with gram-negative pneumonia. Am. J. Respir. Crit. Care Med. 155:2030-2040.
29. Gaboury, J., R. C. Woodman, D. N. Granger, P. Reinhardt, and P. Kubes. 1993. Nitric oxide prevents leukocyte adherence: role of Superoxide. Am. J. Physiol. 265(3 part 2):H862-H867.
30. Gosselin, D., J. DeSanctis, M. Boule, E. Skamene, C. Matouk, and D. Radzioch. 1995. Role of tumor necrosis factor alpha in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa. Infect. Immun. 63:3272-3278.
31. Green, L. C., S. R. Tannenbaum, and P. Goldman. 1981. Nitrate synthesis in the germfree and conventional rat. Science 212:56-58.
32. Greenberger, M. J., R. M. Streiter, S. L. Kunkel, J. M. Danforth, L. L. Laichalk, D. C. McGillicudy, and T. J. Standiford. 1996. Neutralization of MIP-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia. J. Infect. Dis. 173:159-163.
33. Grimminger, F., I. Von Kurten, D. Walmrath, and W. Seeger. 1992. Type II alveolar epithelial eicosanoid metabolism: predominance of cyclooxygenase pathways and transcellular lipoxygenase metabolism in co-culture with neutrophils. Am. J. Respir. Cell. Mol. Biol. 6:9-16.
34. Gross, S. S., and M. S. Wolin. 1995. Nitric oxide: pathophysiological mechanisms. Annu. Rev. Physiol. 57:737-769.
35. Gutierrez, H. H., B. R. Pitt, M. Schwarz, S. C. Watkins, C. Lowenstein, I. Caniggia, P. Chumley, and B. A. Freeman. 1995. Pulmonary alveolar epithelial inducible NO synthase gene expression: regulation by inflammatory mediators. Am. J. Physiol. 268(3 part 1):L501-L508.
36. Hennet, T., H. J. Ziltener, K. Frei, and E. Peterhans. 1992. A kinetic study of immune mediators in the lungs of mice infected with influenza A virus. J. Immunol. 149:932-939.
37. Hogg, J. C., and C. M. Doerschuk. 1995. Leukocyte traffic in the lung. Annu. Rev. Physiol. 57:97-114.
38. Hopkins, H., T. Stull, S. Von-Essen, R. A. Robbins, and S. I. Rennard. 1989. Neutrophil chemotactic factors in bacterial pneumonia. Chest 95:1021-1027.
39. Jacobs, E. R., and R. C. Bone. 1986. Clinical indicators in sepsis and septic adult respiratory distress syndrome. Med. Clin. North Am. 70:921-932.
40. Johnston, R. B. J. 1991. Pathogenesis of pneumococcal pneumonia. Rev. Infect. Dis. 13(Suppl. 6):S509-S517.
41. Kageyama, N., M. Miura, M. Ichinose, M. Tomaki, J. Ishikawa, Y. Ohuchi, N. Endoh, and K. Shirato. 1997. Role of endogenous nitric oxide in airway microvascular leakage induced by inflammatory mediators. Eur. Respir. J. 10:13-19.
42. Keller, R., W. Fischer, R. Keist, and S. Bassetti. 1992. Macrophage response to bacteria: induction of marked secretory and cellular activities by lipoteichoic acids. Infect. Immun. 60:3664-3672.
43. Kilbourn, R. G., and O. W. Griffith. 1992. Overproduction of nitric oxide in cytokine-mediated and septic shock. J. Natl. Cancer Inst. 84:827-831.
44. 4 in bronchoalveolar lavage fluid from HIV-infected patients with bacterial pneumonia. Respir. Med. 91:317-321.
45. Kruger, N. J. 1994. The Bradford method for protein quantitation. Methods Mol. Biol. 32:9-15.
46. Laszlo, F., B. J. Whittle, S. M. Evans, and S. Moncada. 1995. Association of microvascular leakage with induction of nitric oxide synthase: effects of nitric oxide synthase inhibitors in various organs. Eur. J. Pharmacol. 283:47-53.
47. Liew, F. Y. 1995. Interactions between cytokines and nitric oxide. Adv. Neuroimmunol. 5:201-209.
48. Lukacs, N. W., and P. A. Ward. 1996. Inflammatory mediators, cytokines, and adhesion molecules in pulmonary inflammation and injury. Adv. Immunol. 62:257-291.
49. Lyons, C. R. 1995. The role of nitric oxide in inflammation. Adv. Immunol. 60:323-355.
50. Mellencamp, M. A., and L. C. Preheim. 1991. Pneumococcal pneumonia in a rat model of cirrhosis: effects of cirrhosis on pulmonary defense mechanisms against Streptococcus pneumoniae. J. Infect. Dis. 163:102-108.
51. Miles, P. R., L. Bowman, and L. Huffman, 1996. Nitric oxide alters metabolism in isolated alveolar type II cells. Am. J. Physiol. 271(1 part 1):L23-L30.
52. Mizgerd, J. P., B. B. Meek, G. J. Kutkoski, D. C. Biullard, A. L. Beaudet, and C. M. Doerschuk. 1996. Selectins and neutrophil traffic: margination and Streptococcus pneumoniae-induced emigration in murine lungs. J. Exp. Med. 184:639-645.
53. Moine, P., E. Vallée, D. E. Azoulay, P. Bourget, J. P. Bedos, J. Bauchet, and J. J. Pocidalo. 1994. In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model. Antimicrob. Agents Chemother. 38:1953-1958.
54. Moncada, S., and A. Higgs. 1993. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329:2002-2012.
55. Moncada, S., and E. A. Higgs. 1991. Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur. J. Clin. Invest. 21:361-374.
56. Moussa, K., H. J. Michie, I. A. Cree, A. C. McCafferty, J. H. Winter, D. P. Dhillon, S. Stephens, and R. A. Brown. 1994. Phagocyte function and cytokine production in community acquired pneumonia. Thorax 49:107-111.
57. Musher, D. M. 1992. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin. Infect. Dis. 14:801-807.
58. Nelson, S., G. J. Bagby, B. G. Bainton, L. A. Wilson, J. J. Thompson, and W. R. Summer. 1989. Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response. J. Infect. Dis. 159:189-194.
59. Ouellet, N., Y. Bergeron, M. Simard, M. Duong, M. Olivier, D. Beauchamp, and M. G. Bergeron. 1997. Beneficial immunomodulation of pneumococcal pulmonary infection with NG-monomethyl-L-arginine, abstr. G-56. In Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
60. Ohkawa, H., N. Ohishi, and K, Yagi. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95:351-358.
61. Pallares, R., J. Linares, M. Vadillo, C. Cabellos, F. Manresa, P. F. Viladrich, R. Martin, and F. Gudiol. 1995. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N. Engl. J. Med. 333:474-486.
62. Pilewski, J. M., and S. M. Albelda. 1993. Adhesion molecules in the lung. An overview. Am. Rev. Respir. Dis. 148:S31-S37.
63. Ponte, C., A. Parra, E. Nieto, and F. Soriano. 1996. Development of experimental pneumonia by infection with penicillin-insensitive Streptococcus pneumoniae in guinea pigs and their treatment with amoxicillin, cefotaxime, and meropenem. Antimicrob. Agents Chemother. 40:2698-2702.
64. Punjabi, C. J., J. D. Laskin, K. J. Pendino, N. L. Goller, S. K. Durham, and D. L. Laskin. 1994. Production of nitric oxide by rat type II pneumocytes: increased expression of inducible nitric oxide synthase following inhalation of a pulmonary irritant. Am. J. Respir. Cell. Mol. Biol. 11:165-172.
65. Puren, A. J., C. Feldman, N. Savage, P. J. Becker, and C. Smith. 1995. Patterns of cytokine expression in community-acquired pneumonia. Chest 107:1342-1349.
66. Rhodes, G. C., A. W. Lykke, J. W. Tepsell, and L. W. Smith. 1989. Abnormal alveolar epithelial repair associated with failure of resolution in experimental streptococcal pneumonia. J. Pathol. 159:245-253.
67. Roilides, E., and P. A. Pizzo. 1992. Modulation of host defenses by cytokines: evolving adjuncts in prevention and treatment of serious infections in immunocompromised hosts. Clin. Infect. Dis. 15:508-524.
68. Rubins, J. B., D. Charboneau, J. C. Paton, T. J. Mitchell, P. W. Andrew, and E. N. Janoff. 1995. Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia. J. Clin. Invest. 95:142-150.
69. Rubins, J. B., P. G. Duane, D. Charboneau, and E. N. Janoff. 1992. Toxicity of pneumolysin to pulmonary endothelial cells in vitro. Infect. Immun. 60: 1740-1746.
70. Rubins, J. B., P. G. Duane, D. Clawson, D. Charboneau, J. Young, and D. E. Niewoehner. 1993. Toxicity of pneumolysin to pulmonary alveolar epithelial cells. Infect. Immun. 61:1352-1358.
71. Sauve, C., E. Azoulay-Dupuis, P. Moine, C. Darras-Joly, V. Rieux, C. Carbon, and J. P. Bedos. 1996. Efficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 40:2829-2834.
72. Schall, T. J. 1994. The chemokines, p. 419-460, In A. W. Thomson (ed.), The cytokine handbook, 2nd ed. Academic Press, San Diego, Calif.
73. Simon, R. H., and R. Paine. 1995. Participation of pulmonary alveolar epithelial cells in lung inflammation. J. Lab. Clin. Med. 126:108-118.
74. Simpson, S. Q., and L. C. Casey. 1989. Role of tumor necrosis factor in sepsis and acute lung injury. Crit. Care Clin. 5:27-47.
75. Skerrett, S. J. 1994. Host defenses against respiratory infection, p. 941-966. In M. S. Niederman (ed.), The medical clinics of North America. Pneumonia: pathogenesis, diagnosis and management. W. B. Saunders Company, Montreal, Québec, Canada.
76. Snyder, S. H., and D. S. Bredt. 1992. Biological roles of nitric oxide. Sci. Am.266:68-77.
77. Standiford, T. J., S. L. Kunkel, M. A. Basha, S. W. Chensue, J. P. Lynch, G. B. Toews, J. Westwick, and R. M. Stricter. 1990. Interleukin-8 gene expression by a pulmonary epithelial cell line; a model for cytokine networks in the lung. J. Clin. Invest. 86:1945-1953.
78. Standiford, T. J., S. L. Kunkel, M. J. Greenberger, L. L. Laichalk, and R. M. Strieter. 1996. Expression and regulation of chemokines in bacterial pneumonia. J. Leukocyte Biol. 59:24-28.
79. Su, T. H., and W. J. Martin. 1994. Pathogenesis and host response in Pneumocystis carinii pneumonia. Annu. Rev. Med. 45:261-272.
80. Sugawara, T., M. Miyamoto, S. Takayama, and M. Kato. 1995. Separation of neutrophils from blood in human and laboratory animals and comparison of the chemotaxis. J. Pharmacol. Toxicol. Methods 33:91-100.
81. Takashima, K., K. Tateda, T. Matsumoto, Y. lizawa, M. Nakao, and K. Yamaguchi. 1997. Role of tumor necrosis factor alpha in pathogenesis of pneumococcal pneumonia in mice. Infect. Immun. 65:257-260.
82. Takashima, K., K. Tateda, T. Matsumoto, T. Ito, Y. Iizawa, M. Nakao, and K. Yamaguchi. 1996. Establishment of a model of penicillin-resistant Streptococcus pneumoniae pneumonia in healthy CBA/J mice. J. Med. Microbiol. 45:319-322.
83. Talbot, U. M., A. W. Paton, and J. C. Paton. 1996. Uptake of Streptococcus pneumoniae by respiratory epithelial cells. Infect. Immun. 64:3772-3777.
84. Terada, L. S., and J. E. Repine. 1992. Oxygen radicals and lung disease, p. 159-174. In A. P. Fishman (ed.), Update: pulmonary diseases and disorders. McGraw-Hill, Montreal, Québec, Canada.
85. Tsai, W. C., R. M. Strieter, D. A. Zisman, J. M. Wilkowski, K. A. Bucknell, G. H. Chen, and T. J. Standiford. 1997. Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae. Infect. Immun. 65:1870-1875.
86. Tuomanen, E. I., R. Austrian, and H. R. Masure. 1995. Pathogenesis of pneumococcal infection. N. Engl. J. Med. 332:1280-1284.
87. Ulich, T. R., L. R. Watson, S. Yin, K. Guo, P. Wang, H. Thang, and J. D. Castillo. 1991. The intratracheal administration of endotoxin and cytokines. I. Characterization of LPS-induced IL-1 and TNF mRNA expression and the LPS-, IL-1, and TNF-induced inflammatory infiltrate. Am. J. Pathol. 138: 1485-1496.
88. Vallée, E., E. Azoulay-Dupuis, J. J. Pocidalo, and E. Bergogne-Berezin. 1992. Activity and local delivery of azithromycin in a mouse model of Haemophilus influenzae lung infection. Antimicrob. Agents Chemother. 36:1412-1417.
89. Van der Poll, T., C. V. Keogh, W. A. Buurman, and S. F. Lowry. 1997. Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice. Am. J. Respir. Crit. Care Med. 155: 603-608.
90. Van der Poll, T., A. Marchant, C. V. Keogh, M. Goldman, and S. F. Lowry. 1996. Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J. Infect. Dis. 174:994-1000.
91. Veber, B., E. Vallée, J. M. Desmonts, J. J. Pocidalo, and D. E. Azoulay. 1993. Correlation between macrolide lung pharmacokinetics and therapeutic efficacy in a mouse model of pneumococcal pneumonia. J. Antimicrob. Chemother. 32:473-482.
92. Weiss, S. J. 1989. Tissue destruction by neutrophils. N. Engl. J. Med. 320: 365-376.
93. Willis, R. A., A. K. Nussler, K. M. Fries, D. A. Geller, and R. P. Phipps. 1994. Induction of nitric oxide synthase in subsets of murine pulmonary fibroblasts: effect on fibroblast interleukin-6 production. Clin. Immunol. Immunopathol. 71:231-239.
94. Wizemann, T. M., and D. L. Laskin. 1994. Effects of acute endotoxemia on production of cytokines and nitric oxide by pulmonary alveolar and interstitial macrophages. Ann. N. Y. Acad. Sci. 730:336-337.
95. Worthen, G. S., C. Haslett, A. J. Rees, R. S. Gumbay, J. E. Henson, and P. M. Henson. 1987. Neutrophil-mediated pulmonary vascular injury. Am. Rev. Respir. Dis. 136:19-28.